As part of Texas Children’s Cancer Center, the Developmental
Therapeutics Program has achieved national recognition as a
major leader in the development of novel chemotherapy
approaches to pediatric cancer treatment.
Members of the program include physicians board-certified in
pediatric hematology-oncology, clinical pharmacology, hospice
and palliative medicine, as well as post-doctoral fellows, clinical
research nurses, nurse practitioners, data managers and laboratory
research associates. Program investigators have developed and
led numerous national early phase and pharmacokinetic studies,
and they also have expertise in pharmacokinetic-pharmacodynamic
modeling including population pharmacokinetics.
We view referring physicians as partners in care, and keep them
informed throughout the entire process of referral, evaluation,
diagnosis, treatment and follow-up.
Clinical trials
We participate in every major pediatric oncology and
pharmacology cooperative group, providing our patients access
to cutting-edge therapy for pediatric malignancies. Our program
is a major contributor to the Children’s Oncology Group (COG)
Phase I Consortium and is the only COG Phase 1 institution in
the southwestern United States. In addition, we are one of only
three Alex's Lemonade Stand Developmental Therapeutics
Centers of Excellence in the nation. As leading researchers, our
physicians develop nationwide studies for the COG and the
Pediatric Brain Tumor Consortium.We also work closely with
industry to make important new agents available for children
with cancer.
The Developmental Therapeutics Program offers phase 1 and
other early phase clinical trials for a wide range of children’s
cancers.We work closely with referring physicians and families
to identify appropriate options for each individual child and
to support the child and the whole family through the entire
treatment process.
referrals
Referring physicians and families may contact the Developmental
Therapeutics Program by calling 832-824-4570 or 1-800-226-2379.
For more information, please visit
txch.org/cancer-center/clinical-pharmacology-program.
Texas Children’s CanCerand hemaTology CenTers
developmental Therapeutics
Program
Founded in 1994, the DevelopmentalTherapeutics Program focuses on the preclinical and clinical
development of new agents to treat pediatric malignancies.
txch.org/cancer-center/clinical-pharmacology-program
